Monitoring of platelet activation in platelet concentrates using transmission electron microscopy.

Josef Neumüller, Claudia Meisslitzer-Ruppitsch, Adolf Ellinger, Margit Pavelka, Christof Jungbauer, Renate Renz, Gerda Leitner, Thomas Wagner
Author Information
  1. Josef Neumüller: Medical University of Vienna, Center for Anatomy and Cell Biology, Department of Cell Biology and Ultrastructure Research, Medical University of Vienna, Vienna, Austria.

Abstract

OBJECTIVE: The quality of platelet concentrates (PC) is important for the in vivo recovery of thrombostasis in patients suffering from bleeding disorders and in tumor patients after chemotherapy. In this respect, activated platelets (PLT) cannot display their full functionality in the recipient and even can cause adverse effects. Therefore, we developed a transmission electron microscopy (TEM) method for quality assessment of PC.
METHODS: Score values taken from panorama TEM images describe the progress of PLT activation. To exemplify this method, i) 19 apheresis PC isolated with the Baxter Amicus system (BA) were compared with 14 PC obtained from pooled buffy coats (BC). ii) The score values of 33 PC derived from BA as well from BC were compared with flow-cytometric CD62P determinations by cross correlation. iii) Changes in the score value profiles during storage of a single pathogen-reduced BA PC were monitored over a period of 7 days.
RESULTS: The TEM evaluation described allows for demonstrating particular PLT activation stages. i) Significant differences between the percentages of the score values 0, 1 and 2 could be demonstrated in both processing groups. No significant differences were found comparing these two groups. ii) A weak correlation could be shown when comparing the percentages of score values 2 plus 3 with the percentage of CD62P-positive PLT. iii) The pathogen reduction affected slightly the score profiles during storage due to an increase of dead PLT.
CONCLUSION: Our investigations demonstrate the unique detailed quality information of PC obtained by the TEM method. This method can be performed in every routine electron microscopy laboratory.

Keywords

References

  1. Transfusion. 2006 Nov;46(11):2004-10 [PMID: 17076857]
  2. Transfus Med Hemother. 2008;35(5):368-373 [PMID: 21512626]
  3. Am J Pathol. 1986 Nov;125(2):319-26 [PMID: 3098108]
  4. Prog Clin Biol Res. 1988;283:1-32 [PMID: 3062624]
  5. Transfus Apher Sci. 2011 Feb;44(1):11-3 [PMID: 21277261]
  6. Transfusion. 2012 Oct;52(10):2094-103 [PMID: 22320126]
  7. Vox Sang. 2010 Nov;99(4):332-40 [PMID: 20546206]
  8. Transfusion. 2009 Aug;49(8):1564-8 [PMID: 19392772]
  9. Thromb Res. 2001 Jan 15;101(2):73-81 [PMID: 11342208]
  10. J Clin Apher. 2001;16(1):10-4 [PMID: 11309824]
  11. Transfusion. 2004 Nov;44(11):1612-20 [PMID: 15504167]
  12. Transfusion. 2000 Jul;40(7):789-93 [PMID: 10924605]
  13. Transfus Apher Sci. 2002 Feb;26(1):37-41 [PMID: 11931376]
  14. Transfus Apher Sci. 2012 Feb;46(1):33-7 [PMID: 22119364]
  15. Transfus Med Rev. 2007 Oct;21(4):287-94 [PMID: 17900490]
  16. Methods Achiev Exp Pathol. 1979;9:1-39 [PMID: 216889]
  17. Microsc Electron Biol Celular. 1988 Jun;12(1):1-15 [PMID: 3253514]
  18. Blood. 2008 May 1;111(9):4605-16 [PMID: 18230754]
  19. Vox Sang. 2011 Jul;101(1):1-9 [PMID: 21668862]
  20. Blood. 2010 Aug 19;116(7):1147-56 [PMID: 20439620]
  21. Ann Hematol. 1996 Sep;73(3):103-12 [PMID: 8841097]
  22. Transfusion. 2006 Sep;46(9):1601-8 [PMID: 16965590]
  23. Transfusion. 2009 Jan;49(1):91-8 [PMID: 18954408]
  24. Methods Mol Biol. 2004;272:47-63 [PMID: 15226533]
  25. Blood Rev. 2012 Mar;26(2):51-63 [PMID: 22055392]
  26. Haemostasis. 1978;7(4):242-51 [PMID: 658788]
  27. Vox Sang. 2003 Nov;85(4):267-75 [PMID: 14633252]
  28. Transfus Apher Sci. 2011 Jun;44(3):305-19 [PMID: 21601530]
  29. Transfusion. 2004 Jan;44(1):125-30 [PMID: 14692978]
  30. Blood. 1999 Apr 1;93(7):2422-5 [PMID: 10215351]
  31. Transfus Clin Biol. 2012 Jun;19(3):90-7 [PMID: 22677430]
  32. Platelets. 2008 Sep;19(6):455-66 [PMID: 18925514]
  33. Transfusion. 2007 Jun;47(6):987-94 [PMID: 17524087]
  34. Thromb Res. 2001 Dec 1;104(5):361-70 [PMID: 11738079]
  35. Transfusion. 2004 Jan;44(1):119-24 [PMID: 14692977]
  36. J Clin Apher. 1998;13(2):47-55 [PMID: 9704605]
  37. Curr Opin Hematol. 2003 Nov;10(6):419-23 [PMID: 14564171]
  38. Indian J Med Res. 1997 Feb;105:77-84 [PMID: 9055500]
  39. Vox Sang. 1981;40 Suppl 1:62-8 [PMID: 7293122]
  40. Blood. 2003 Jun 15;101(12):4789-96 [PMID: 12586623]
  41. Blood Cells. 1983;9(2):237-61 [PMID: 6661559]
  42. Eur J Cell Biol. 1991 Dec;56(2):233-42 [PMID: 1802710]
  43. Transfusion. 2002 Jun;42(6):719-27 [PMID: 12147024]
  44. Transfusion. 2010 Oct;50(10):2210-9 [PMID: 20456708]
  45. Transfus Med Rev. 2006 Jan;20(1):1-26 [PMID: 16373184]

Word Cloud

Created with Highcharts 10.0.0PCPLTscoreplateletelectronmicroscopyTEMmethodvaluesactivationqualityconcentratesBApatientscantransmissioncomparedobtainedBCiicorrelationiiiprofilesstoragedifferencespercentages2groupscomparingOBJECTIVE:importantvivorecoverythrombostasissufferingbleedingdisorderstumorchemotherapyrespectactivatedplateletsdisplayfullfunctionalityrecipientevencauseadverseeffectsThereforedevelopedassessmentMETHODS:Scoretakenpanoramaimagesdescribeprogressexemplify19apheresisisolatedBaxterAmicussystem14pooledbuffycoats33derivedwellflow-cytometricCD62PdeterminationscrossChangesvaluesinglepathogen-reducedmonitoredperiod7daysRESULTS:evaluationdescribedallowsdemonstratingparticularstagesSignificant01demonstratedprocessingsignificantfoundtwoweakshownplus3percentageCD62P-positivepathogenreductionaffectedslightlydueincreasedeadCONCLUSION:investigationsdemonstrateuniquedetailedinformationperformedeveryroutinelaboratoryMonitoringusingPlateletQualitycontrolTransmissionUltrastructure

Similar Articles

Cited By